Reboot Your Cells with MOTS-c Therapy
A 16‑amino‑acid mitochondrial peptide that mimics exercise‑induced energy boosting.
MOTS‑c (Mitochondrial Open‑Reading‑frame of the 12S rRNA type‑C) is a tiny 16‑amino‑acid peptide produced by our own mitochondria. Dr. Jason Schuster explains that restoring its levels can revitalize cellular energy production and address chronic fatigue.
A mitochondrial‑derived peptide
MOTS‑c is encoded by the 12S RNA segment of mitochondrial DNA and consists of only 16 amino acids—far smaller than peptides like Thymosin β4. Because it originates from the mitochondria, it works directly on the organelle that generates ATP, the body’s power currency.
- 16 amino acids long
- Encoded by mitochondrial 12S rRNA
- Naturally produced during exercise
Improves mitochondrial‑nuclear communication
Dr. Schuster describes MOTS‑c as a messenger that enhances dialogue between mitochondrial DNA and nuclear DNA. This signaling boosts NAD⁺ levels inside mitochondria, supports the citric‑acid cycle, and activates the NRF2 anti‑inflammatory pathway, thereby improving ATP synthesis and gene expression.
- Elevates intracellular NAD⁺
- Activates NRF2 anti‑inflammatory signaling
- Facilitates mitochondrial‑nuclear DNA cross‑talk
Energy, metabolism and longevity
When mitochondrial function is optimized, Dr. Schuster notes a cascade of health effects: increased energy, better insulin sensitivity, reduced inflammation, and support for cardiovascular health. He also ties higher MOTS‑c levels to improved metabolic oxidation and potential lifespan extension.
- Reduces chronic fatigue
- Improves insulin resistance and glucose flux
- Lowers pro‑inflammatory cytokines (TNF‑α, IL‑1, IL‑6)
- Raises anti‑inflammatory cytokines (IL‑10)
- Supports cardiovascular recovery and weight management
Low‑frequency protocol
The video cites Dr. Edin Lee’s protocol of 10 mg subcutaneous MOTS‑c administered once or twice a year, or on a rotational schedule (one‑to‑two‑month blocks with equal off‑periods). No serious adverse effects were reported, and the peptide is described as “super safe” and “natural.”
- 10 mg subcutaneously, weekly in some protocols
- Typical schedule: 1–2 months on, 1–2 months off
- Only once or twice per year in the author’s preferred regimen
- No major side‑effects reported in the video
“MOTS‑c works like a bypass for exercise, delivering the same energy‑boosting benefits without the workout.”— Dr. Jason Schuster
Go deeper than the summary
Dr. Schuster's board-certified, accredited peptide therapy courses — the full research, dosing, and video breakdowns.